Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 February 2018 Photo Earl Coetzee
Faculty of Health Sciences welcomes new Vice-Dean Prof Joyce Tsoka-Gwegweni
Prof Joyce Tsoka-Gwegweni, Vice-Dean for Research, Transformation, and Marketing in the Faculty of Health Sciences.

The Faculty of Health Sciences at the University of the Free State is proud to introduce the new Vice-Dean for Research, Transformation, and Marketing – Prof Joyce Tsoka-Gwegweni. This seasoned academic has 24 years of health science research experience and holds a PhD (University of KwaZulu-Natal), two master’s degrees (MSc from the University of Natal; MPH from the University of the Western Cape), two honours degrees (BSc Hons from the University of Reading; BA Hons from the University of South Africa) and management diplomas and certificates from reputable local and international institutions (University for Durham, University of Stellenbosch, UKZN, Unisa). She has also published more than 50 papers and held various high-profile leadership positions.

Prof Tsoka-Gwegweni joined the UFS on 1 February 2018.

“I think I am at the right place,
at the right time, for the right
reasons. I do not regret choosing
the UFS.”

A born academic
“I went for a scholarship interview with the British Council in 1987, and they asked me what job I’d like after studying,” Prof Tsoka-Gwegweni remembers. “I told the interview panel that I planned to work at the university!” She studied for A-levels, a junior degree and postgraduate qualifications in the UK, and further postgraduate studies in South Africa.

No place like home

Having experienced various locations around the world, South Africa remains her favourite. “I won’t trade the beautiful weather and nature, or the friendly atmosphere and people for anything from abroad,” she says. “But had I not gone to the UK, I would not have learnt to appreciate South Africa as my country.”

Big plans for Health Science research
Prof Tsoka-Gwegweni hopes for an adequate health workforce for South Africa, which is competent, committed and caring. In the Faculty of Health Sciences, she hopes to drive research by providing research leadership. “I would like to encourage the staff to enjoy research and not see it as a burden. My ambition is to improve our research profile towards a top research faculty.”

At peace in the City of Roses
Off campus, Prof Tsoka-Gwegweni enjoys going to church, listening to gospel music and going to concerts, reading, travelling, and nature. “I’m looking forward to having a great and rewarding time in Bloemfontein. But more importantly, to make a positive impact,” she says, “no matter how small. I think I am at the right place, at the right time, for the right reasons. I do not regret choosing the UFS.”

 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept